1
|
Teasdale A, Popkin M. Regulatory Highlights. Org Process Res Dev 2022. [DOI: 10.1021/acs.oprd.2c00257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Andrew Teasdale
- Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, United Kingdom
- Snr Director, CMC Excellence, GSK CMC Regulatory Affairs, Park Road, Ware, SG12 0DP, United Kingdom
| | - Matthew Popkin
- Chemical Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield SK10 2NA, United Kingdom
- Snr Director, CMC Excellence, GSK CMC Regulatory Affairs, Park Road, Ware, SG12 0DP, United Kingdom
| |
Collapse
|